Target intelligence / Profile preview

Heterogeneous nuclear ribonucleoprotein A1 pseudogene 13 (HNRNPA1P13)

Target: HNRNPA1P13
Molecular classification: Other (Pseudogene)

Overview

Heterogeneous nuclear ribonucleoprotein A1 pseudogene 13 (HNRNPA1P13) is a pseudogene that shares homology with the HNRNPA1 gene, which encodes a ubiquitously expressed RNA-binding protein involved in mRNA splicing, export, and translation regulation. As a pseudogene, HNRNPA1P13 does not encode a functional protein. Emerging evidence suggests that some pseudogenes can be transcribed and participate in regulatory networks, potentially influencing gene expression or acting as competitive endogenous RNAs (ceRNAs), but no specific regulatory or pathological role has been established for HNRNPA1P13 itself. It should not be considered a canonical drug target or receptor, and there is no evidence of clinical drugs interacting with it.

Other names: HNRNPA1P13heterogeneous nuclear ribonucleoprotein A1 pseudogene 13

Biological functions

Possible roles in regulation of gene expression via RNA mechanisms (the parental gene HNRNPA1 has functions in RNA binding, splicing, export, and stress responses, but these do not apply directly to the pseudogene unless transcriptional or regulatory activity is demonstrated)

Disease associations

Other (Pseudogenes may have context-dependent regulatory effects, especially in cancer as competitive endogenous RNAs, but direct disease roles for HNRNPA1P13 are not established)

Beyond the preview

Go deeper on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 13 (HNRNPA1P13).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 13 (HNRNPA1P13).

Explore the full profile